|Articles|April 5, 2017
Schulman IRB Partners with iMedRIS to Develop IBC Technology
Schulman IRB announced that research compliance and administration software provider iMedRIS Data is developing the technology to power Schulman’s forthcoming institutional biosafety committee (IBC) service.
Advertisement
Schulman IRB announced that research compliance and administration software provider iMedRIS Data is developing the technology to power Schulman’s forthcoming institutional biosafety committee (IBC) service.
Read the full release
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
Breaking the Efficacy Ceiling in IBD and Beyond
2
The Career They Didn't Train For: Rethinking Early-Career Burnout in Clinical Research
3
ACT Brief: Substance Versus Branding in Biotech Support, Site-Level Execution Gaps and Point-of-Care Data, and KCNT1-Targeted Pediatric Epilepsy Program
4
Why Clinical Trial Modernization Fails Without Point-of-Care Data: Q&A with Richard Graham, PhD, TruTechnologies
5